Medicare Enrolled
Dr. Olivia Ryder, DO
Neurology · Farmington Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ryder from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ryder?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ryder
Dr. Olivia Ryder is a neurology specialist in Farmington Hills, MI, with 9 years of NPI registration. Based on federal Medicare data, Dr. Ryder performed 777 Medicare services across 639 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ryder received a total of $13,123 from 63 pharmaceutical and/or device companies across 777 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ryder is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice
▲ Top 20% volume in MI
$13,123 industry payments
Medicare Practice Summary
Medicare Utilization ↗777
Medicare services
Top 20% in MI for neurology
639
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
271 | $89 | $160 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
151 | $130 | $287 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
139 | $59 | $102 |
| New patient office visit, complex (60-74 min) | 98 | $157 | $304 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
54 | $90 | $147 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $63 | $114 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $125 | $224 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
16 | $38 | $56 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,123
Total received (2018-2024)
Avg $1,875/year across 7 years
Top 20% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
777
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,925 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$198 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,575
2023
$3,029
2022
$3,466
2021
$446
2020
$108
2019
$1,080
2018
$420
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$501
Novartis Pharmaceuticals Corporation
$480
Celgene Corporation
$411
UCB, Inc.
$279
PFIZER INC.
$255
Alexion Pharmaceuticals, Inc.
$225
Takeda Pharmaceuticals U.S.A., Inc.
$210
Biogen, Inc.
$194
Lilly USA, LLC
$180
Amgen Inc.
$175
ANI Pharmaceuticals, Inc.
$174
EMD Serono, Inc.
$165
TG Therapeutics, Inc.
$143
Lundbeck LLC
$127
Alnylam Pharmaceuticals Inc.
$115
Neurocrine Biosciences, Inc.
$110
Eisai Inc.
$107
Genentech USA, Inc.
$91
ACADIA Pharmaceuticals Inc
$76
Neurelis, Inc.
$71
Amneal Pharmaceuticals LLC
$58
Sumitomo Pharma America, Inc.
$57
Otsuka America Pharmaceutical, Inc.
$51
Kyowa Kirin, Inc.
$47
HARMONY BIOSCIENCES LLC
$43
Otsuka Pharmaceutical Development & Commercialization, Inc.
$41
MITSUBISHI TANABE PHARMA AMERICA, INC.
$35
CATALYST PHARMACEUTICALS, INC.
$23
HOSPIRA, INC.
$22
JAZZ PHARMACEUTICALS INC.
$21
ARGENX US, INC.
$20
SK Life Science, Inc.
$20
Azurity Pharmaceuticals, Inc.
$19
ALK-Abello, Inc
$16
Aucta Pharmaceuticals, Inc.
$10
Top 3 companies account for 30.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,028
Celgene Corporation
$965
ABBVIE INC.
$932
GENZYME CORPORATION
$829
UCB, Inc.
$814
Genentech USA, Inc.
$674
PFIZER INC.
$471
AbbVie Inc.
$465
Biogen, Inc.
$449
Janssen Pharmaceuticals, Inc
$438
Alexion Pharmaceuticals, Inc.
$386
Neurocrine Biosciences, Inc.
$314
Takeda Pharmaceuticals U.S.A., Inc.
$312
Horizon Therapeutics plc
$287
Teva Pharmaceuticals USA, Inc.
$286
Amgen Inc.
$243
Lundbeck LLC
$235
Lilly USA, LLC
$231
EMD Serono, Inc.
$227
ANI Pharmaceuticals, Inc.
$190
Alnylam Pharmaceuticals Inc.
$189
Amneal Pharmaceuticals LLC
$180
ACADIA Pharmaceuticals Inc
$176
IMPEL PHARMACEUTICALS INC.
$167
Kyowa Kirin, Inc.
$158
Neurelis, Inc.
$154
SK Life Science, Inc.
$152
Sumitomo Pharma America, Inc.
$147
Corium, LLC
$143
TG Therapeutics, Inc.
$143
Eisai Inc.
$141
ARGENX US, INC.
$140
CSL Behring
$126
Alkermes, Inc.
$125
US WorldMeds, LLC
$123
JAZZ PHARMACEUTICALS INC.
$109
Otsuka America Pharmaceutical, Inc.
$91
HARMONY BIOSCIENCES LLC
$61
Avanir Pharmaceuticals, Inc.
$53
Harmony Biosciences LLC
$53
Cala Health, Inc.
$52
Sunovion Pharmaceuticals Inc.
$52
Biohaven Pharmaceuticals, Inc.
$51
Supernus Pharmaceuticals, Inc.
$49
CATALYST PHARMACEUTICALS, INC.
$48
Zogenix Inc.
$46
Otsuka Pharmaceutical Development & Commercialization, Inc.
$41
Scilex Pharmaceuticals Inc.
$40
Biohaven Pharmaceutical Holding Company Ltd.
$38
Azurity Pharmaceuticals, Inc.
$36
Acorda Therapeutics, Inc
$36
MITSUBISHI TANABE PHARMA AMERICA, INC.
$35
Catalyst Pharmaceuticals, Inc.
$24
TG THERAPEUTICS, INC.
$22
Medtronic, Inc.
$22
HOSPIRA, INC.
$22
Collegium Pharmaceutical, Inc.
$20
ALK-Abello, Inc
$16
GE HealthCare
$15
Allergan, Inc.
$15
AstraZeneca Pharmaceuticals LP
$13
Mallinckrodt Hospital Products Inc.
$12
Aucta Pharmaceuticals, Inc.
$10
Top 3 companies account for 22.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · AGAMREE · AJOVY · AMYVID · APOKYN · APTIOM · ARISTADA · ASCENDA · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · BOTOX · BRILINTA · BRIUMVI · Briviact · CALA TRIO · COMIRNATY · CREXONT · Cenobamate · DUOPA · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Enspryng · FIRDAPSE · FYCOMPA · Fintepla · GAMMAGARD · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · Motpoly XR · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Odactra · Ongentys · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RADICAVA · REXULTI · RYTARY · Rystiggo · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYEPTI · VYVGART · WAKIX · Wakix · XCOPRI · XYWAV · ZAVZPRET · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
364
Per 100K population
28.6
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL - FARMINGTON HILLS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ryder is a clinical cardiology specialist, with above-average Medicare volume (top 20% in MI), with low-engagement industry engagement in the top 20% of MI peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ryder experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ryder performed 271 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ryder receive payments from pharmaceutical companies?
Yes. Dr. Ryder received a total of $13,123 from 63 companies across 777 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ryder's costs compare to other neurologists in Farmington Hills?
Dr. Ryder's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ryder) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Farmington Hills
Browse neurologists in Farmington Hills ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MI
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MI
Which MI neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology